NCT07430449Completed
The Effect of Education Given According to Roy's Adaptation Model
The Effect of Education Given According to Roy's Adaptation Model to Kidney Patients Undergoing Immunosuppressive Therapy on Self-Efficacy, Immunosuppressive Therapy, and Chronic Disease Adaptation Levels
Source: ClinicalTrials.gov · Last updated 24 Feb 2026
Brief summary (registry, in English)
Background and Aim: Immunosuppressive therapies administered after chronic kidney disease and kidney transplantation are critically important for patients' life adaptation and the continued success of transplantation. However, the process of compliance with immunosuppressive therapy is not limited to regular medication use; it is closely related to multidimensional factors such as disease adjustment, physical adjustment, psychological balance, social functioning, and the individual's level of self-efficacy. This study aimed to examine the effect of Roy's Adaptation Model-based education on the adherence of patients with chronic kidney disease or kidney transplantation undergoing immunosuppressive therapy to immunosuppressive therapy, their adaptation to the disease, and their self-efficacy levels. Material and Methods: This quasi-experimental study with a pretest-posttest control group design was conducted with 78 chronic kidney disease patients who were scheduled to receive immunosuppressive therapy for the first time between November 2024 and June 2025 at the nephrology and transplantation services of a university hospital. Data were collected using the "Patient Information Form," "Immunosuppressive Drug Adherence Scale," "Chronic Disease Coping Scale," and "General Self-Efficacy Scale."
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 78 (actual)
- First submitted
- 15 Jan 2026
- Start date
- 1 Nov 2024
- Primary completion date
- 15 Jun 2025
- Lead sponsor
- Trakya University
- Diseases
- Chronic kidney disease
- NCT number
- NCT07430449
What you commit to
- Study type: Interventional
- Participants enrolled: 78
- From 1 Nov 2024 to the primary completion date, 15 Jun 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients undergoing dialysis treatment and not receiving immunosuppressive therapy
Other
- Patients who are not willing to participate in the study,
- Patients who are illiterate,
- Patients with communication or mental problems,
- Patients with motor skill problems,
- Patients who wish to withdraw from the study at any stage,
- Patients who do not attend follow-up appointments,
Who the study is looking for
- Patients receiving immunosuppressive therapy for the first time at the nephrology and transplantation clinics of Trakya University Hospital,
- Aged 18 years or older,
- Literate,
- Without communication or mental disorders,
- Without motor skill impairments,
- Patients who consent to participate in the study
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Trakya University Hospital Coordinator of this site? Confirm its status | Edirne | Turkey (Türkiye) | Unknown status |
Related publications
This page is information, not medical advice. Discuss any trial with your doctor.